サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631478

うっ血性心不全治療装置の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント別予測、2025年～2030年

Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Devices, Implantable Cardioverter Defibrillators, Counter Pulsation Devices, Pacemakers), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
うっ血性心不全治療装置の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年12月17日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

うっ血性心不全治療装置市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のうっ血性心不全治療装置市場規模は2030年に82億米ドルに達すると予測され、2025～2030年にかけてCAGR 6.7％で成長すると予測されています。

CVDの負担増は、このセグメントの有利な成長の主要要因の1つです。座りがちなライフスタイル、精神的ストレス、ジャンクフード消費傾向はCVDs開発の主要要因です。

米国のメディケア制度のような好意的な償還施策は、この産業の主要な成長要因であると見られています。各社は現在、患者にとってメリットのある払い戻しが適用される新製品プラットフォームを提供しています。CHFの治療に使用される補助人工心臓（VAD）、植込み型除細動器（ICD）、ペースメーカーなどの装置に償還が適用されます。

産業関係者は、個別化されたケアを提供できる実用性の高い製品の開発に力を入れています。これらの進歩は、精度を向上させ、ワークフローを強化し、エラーの発生率を低減するための追加機能を提供しています。

うっ血性心不全治療装置市場のレポートハイライト

  • 製品別市場は、補助人工心臓、カウンターパルセーション装置、ICD、ペースメーカー、心臓再同期装置に区分されます。経静脈型と皮下型の2種類からなるICDセグメントが2024年に有利なシェアを占め、これにペースメーカーセグメントが続きます。これは、除細動器とペースメーカーが心不全治療の第一線を担っていることに起因しています。
  • 一方、補助人工心臓（VAD）セグメントは、保険償還の適用範囲と補助人工心臓の技術的進歩により、予測期間中に大きな成長が見込まれています。
  • 補助人工心臓は、移植部位によって左心室補助人工心臓（LVAD）と右心室補助人工心臓（RVAD）に分類されます。LVADとRVADが一緒に植え込まれる場合は、両心室補助装置（BIVAD）と呼ばれます。
  • 北米のうっ血性心不全治療装置市場は、2024年に45.6%のシェアで世界市場を独占しました。これは、CVDに罹患している人口ベースが大きいことと、高齢者ベースが大きいことに起因しています。
  • 市場参入企業は、市場での地位を維持するため、現在の製品ポートフォリオの改善に積極的に取り組んでいます。さらに、市場開拓と未開拓国への市場参入が市場成長を促進すると期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 うっ血性心不全治療装置市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • うっ血性心不全治療装置市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 うっ血性心不全治療装置市場：製品別、推定・動向分析

  • 世界のうっ血性心不全治療装置市場：製品ダッシュボード
  • 世界のうっ血性心不全治療装置市場：製品変動分析
  • うっ血性心不全治療装置の世界市場（製品別、収益別）
  • 補助人工心臓（VAD）
    • LVAD
    • RVAD
    • ビバッド
  • カウンターパルセーション装置
  • 植込み型除細動器
    • 経静脈ICD
    • 皮下ICD
  • ペースメーカー
    • 埋め込み型
    • 外付け型
  • 心臓再同期療法
    • 心臓再同期療法除細動器（CRT-D）
    • 心臓再同期療法ペースメーカー（CRT-P）

第5章 うっ血性心不全治療装置市場：地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析、2024年
    • Jarvik Heart Inc.
    • ReliantHeart, Inc.
    • BIoTronik SE &Co. KG
    • Berlin Heart GmbH
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Teleflex, Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Mexico congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 Germany congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 UK congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 France congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Italy congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Spain congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Denmark congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Sweden congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Norway congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 China congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 Japan congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 India congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 South Korea congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Australia congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Thailand congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Brazil congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 MEA congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 South Africa congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Congestive heart failure treatment devices market: market outlook
  • Fig. 7 Congestive heart failure treatment devices competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Congestive heart failure treatment devices market driver impact
  • Fig. 11 Congestive heart failure treatment devices market restraint impact
  • Fig. 12 Congestive heart failure treatment devices market: Product movement analysis
  • Fig. 13 Congestive heart failure treatment devices market: Product outlook and key takeaways
  • Fig. 14 Ventricular assist devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 LVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 RVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 BiVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Counter pulsation devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Implantable cardioverter defibrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Transvenous ICDs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Subcutaneous ICDs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Pacemakers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Implantable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 External market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Cardiac resynchronization therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cardiac resynchronization therapy-defibrillators (CRT-D) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiac resynchronization therapy-pacemakers (CRT-P) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global congestive heart failure treatment devices market: Regional movement analysis
  • Fig. 29 Global congestive heart failure treatment devices market: Regional outlook and key takeaways
  • Fig. 30 Global congestive heart failure treatment devices market share and leading players
  • Fig. 31 North America, by country
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. key country dynamics
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada key country dynamics
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico key country dynamics
  • Fig. 38 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 UK key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Germany key country dynamics
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France key country dynamics
  • Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China key country dynamics
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan key country dynamics
  • Fig. 60 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India key country dynamics
  • Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand key country dynamics
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea key country dynamics
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina key country dynamics
  • Fig. 73 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa key country dynamics
  • Fig. 76 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia key country dynamics
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 UAE key country dynamics
  • Fig. 80 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait key country dynamics
  • Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Market share of key market players- Congestive heart failure treatment devices market
目次
Product Code: GVR-1-68038-292-1

Congestive Heart Failure Treatment Devices Market Growth & Trends:

The global congestive heart failure treatment devices market size is expected to reach USD 8.2 billion in 2030 and is projected to grow at a CAGR of 6.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2024, which was followed by the pacemaker's segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America congestive heart failure treatment devices market dominated the global market with a 45.6% share in 2024, this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Congestive Heart Failure Treatment Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases
      • 3.2.1.2. Technological advancements in heart failure treatment
      • 3.2.1.3. Growing awareness and early detection of heart failure
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of devices
      • 3.2.2.2. Complications and risks associated with device implantation
  • 3.3. Congestive Heart Failure Treatment Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Congestive Heart Failure Treatment Devices Market: Product Estimates & Trend Analysis

  • 4.1. Global Congestive Heart Failure Treatment Devices Market: Product Dashboard
  • 4.2. Global Congestive Heart Failure Treatment Devices Market: Product Movement Analysis
  • 4.3. Global Congestive Heart Failure Treatment Devices Market by Product, Revenue
  • 4.4. Ventricular Assist Devices
    • 4.4.1. Ventricular assist devices market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. LVAD
      • 4.4.2.1. LVAD market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. RVAD
      • 4.4.3.1. RVAD market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. BiVAD
      • 4.4.4.1. BiVAD market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Counter Pulsation Devices
    • 4.5.1. Counter pulsation devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Implantable Cardioverter Defibrillators
    • 4.6.1. Implantable cardioverter defibrillators market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Transvenous ICDs
      • 4.6.2.1. Transvenous ICDs market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Subcutaneous ICDs
      • 4.6.3.1. Subcutaneous ICDs market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Pacemakers
    • 4.7.1. Pacemakers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Implantable
      • 4.7.2.1. Implantable market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. External
      • 4.7.3.1. External market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Cardiac Resynchronization Therapy
    • 4.8.1. Cardiac resynchronization therapy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.2. Cardiac resynchronization therapy-defibrillators (CRT-D)
      • 4.8.2.1. Cardiac resynchronization therapy-defibrillators (CRT-D) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.3. Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
      • 4.8.3.1. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Congestive Heart Failure Treatment Devices Market: Regional Estimates & Trend Analysis by Product

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. Key company market share analysis, 2024
    • 6.2.2. Jarvik Heart Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. ReliantHeart, Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Biotronik SE & Co. KG
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Berlin Heart GmbH
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Abbott
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Medtronic
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Boston Scientific Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Teleflex, Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives